TTK Healthcare Ltd (TTKHLTCARE) — shareholding pattern, promoter holding, financials and share price
About TTK Healthcare Ltd (TTKHLTCARE)
TTK Healthcare Ltd operates in the Diversified industry. It trades on the NSE as TTKHLTCARE and on the BSE under scrip code 507747. Its ISIN is INE910C01018.
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1] It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India. [2]
TTK Healthcare Limited, part of the TTK Group, offers diversified products across pharmaceuticals, consumer goods, medical devices, and protective devices.
The company has wide geographic exposure with exports to regions including the UK, Egypt, and Caribbean countries, showcasing its global reach.
Listed peers in Diversified: Dhunseri Ventures Ltd, Empire Industries Ltd, Spacenet Enterprises India Ltd, Maheshwari Logistics Ltd, Aspinwall & Company Ltd, Adani Enterprises Ltd Partly Paidup.
Valuation & Returns
10 Jul 2026At ₹922 a share on 10 Jul 2026, TTK Healthcare Ltd (TTKHLTCARE) was valued at a price-to-earnings ratio of 19.84x against an industry P/E of 31.59x and a price-to-book of 1.22x on a book value of ₹753.73 per share as of Mar 2025. Solomo computes return on equity of 6.17% and return on capital employed of 7.85% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 19.84x
- Industry P/E
- 31.59x
- P/B
- 1.22x
- EPS (TTM)
- ₹46.48
- Book value / share
- ₹753.73
- ROE
- 6.17%
- ROCE
- 7.85%
- ROA
- 5.13%
- Debt / equity
- 0.02x
- Dividend yield
- 1.08%
- EBITDA margin
- 10.99%
- 52-week range
- ₹737 – ₹1,402
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, TTK Healthcare Ltd (TTKHLTCARE) reported revenue of ₹857 crore, net profit of ₹66 crore and earnings per share of ₹46.48. That compares with revenue of ₹801 crore and net profit of ₹82 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹218 crore and net profit ₹22 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 599 | 725 | 753 | 801 | 857 |
| Net profit (₹ cr) | 42 | 640 | 63 | 82 | 66 |
| EPS (₹) | 29.43 | 452.72 | 44.47 | 57.79 | 46.48 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 4.94% | 4.42% | 10.18% | 7.59% |
| Profit growth | 15.30% | 45.98% | 64.01% | -19.57% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.56% of TTK Healthcare Ltd (TTKHLTCARE) (unchanged from the previous quarter), foreign institutional investors (FII) hold 1.86% and domestic institutional investors (DII) hold 2.19%. Market capitalisation was ₹1,303 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: ABAKKUS DIVERSIFIED ALPHA FUND 2.07%, JUPITER INDIA FUND 1.52%, Investor Education and Protection Fund (IEPF) 1.05%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.56% | - | 1.86% | 2.19% | 25.44% |
| Mar 2026 | 74.56% | - | 1.9% | 1.11% | 25.44% |
| Dec 2025 | 74.56% | - | 1.89% | 1.08% | 25.44% |
| Sep 2025 | 74.56% | - | 1.9% | 1.18% | 25.44% |
| Jun 2025 | 74.56% | - | 1.89% | 1.18% | 25.44% |
| Mar 2025 | 74.56% | - | 1.9% | 1.14% | 25.44% |
| Dec 2024 | 74.56% | - | 1.9% | 1.14% | 25.44% |
| Sep 2024 | 74.56% | - | 1.9% | 1.14% | 25.44% |